Atrial fibrillation and heart failure: natural history and pharmacological treatment.
about
Ventricular assist devices: pharmacological aspects of a mechanical therapyNoninvasive detection of left-ventricular systolic dysfunction by acoustic cardiography in atrial fibrillation.Heart failure and atrial fibrillation: from basic science to clinical practiceInflammatory markers in paroxysmal atrial fibrillation and the protective role of renin-angiotensin-aldosterone system inhibitors.Methods for the development and assessment of atrial fibrillation and heart failure dog modelsIs atrial fibrillation an inflammatory disorder?Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillationBeneficial effects of an angiotensin-II receptor blocker on structural atrial reverse-remodeling in a rat model of ischemic heart failure.Prevention of atrial fibrillation by bucindolol is dependent on the beta₁389 Arg/Gly adrenergic receptor polymorphism.The CHA2DS2-VASc score as a predictor of high mortality in hospitalized heart failure patientsAtrial Fibrillation in Patients with Ischemic and Non-Ischemic Left Ventricular Dysfunction.Heart failure, diastolic dysfunction and atrial fibrillation; mechanistic insight of a complex inter-relationship.Lone atrial fibrillation: what is known and what is to come.Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.Atrial fibrillation in elderly patients with heart failure: convergence of two cardiovascular epidemics in the 21st Century.Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation.Biomarkers in atrial fibrillation: a clinical review.Biomarkers in atrial fibrillation: an overview.Catheter ablation of atrial fibrillation in chronic heart failure: state-of-the-art and future perspectives.Post-operative Atrial Fibrillation - Pathophysiology, Treatment and Prevention.Pharmacokinetic drug evaluation of bucindolol for the treatment of atrial fibrillation in heart failure patients.Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation.Right heart failure due to loss of right ventricular capture in a patient with atrioventricular junction ablation and biventricular pacing.A pilot study to assess benefit of atrial rhythm control after cardiac resynchronization therapy and atrioventricular node ablation.Echocardiographic measures of atrial function may predict atrial fibrillation in stroke patients.The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice.How to manage various arrhythmias and sudden cardiac death in the cardiovascular intensive care.Pharmacological therapy for atrial fibrillation: current options and new agents
P2860
Q27002612-987F9654-D2D0-4903-9A57-E7C3F0D53704Q30479026-88C77521-E9BC-438D-BBCE-977378FAB52FQ35138993-8970CC5D-9FE4-484D-AB8A-DFFC2F1F5DB1Q35714328-34FDF38D-B425-4051-BF1E-F9EC3CBA5B50Q36077270-44AC5BF8-FCBA-4535-B81F-A747F7502303Q36309624-45D23E2F-525F-4C1B-A6A7-F4DC9948B7B7Q36623045-DFD9C3BA-CD5E-4F3A-979F-447918EDF4F6Q36773693-4CCE13C7-3741-4730-8D82-F5A192EBF807Q37245081-2B98C5A4-8A6C-4187-90B9-FA7DA766C2ADQ37411934-00DFB975-A6F1-41BC-A05A-A4BB2051388AQ37495914-9144DD66-CA01-42C9-BD56-9094226E995AQ37811953-C97DBDF5-7B43-4C7F-BB7A-342D423AD721Q37827195-EA972DF0-4562-4B61-9C0A-766C277CF20AQ37846370-EDCAF0B0-C744-4389-A301-A58A182784C7Q37910212-047B1829-D1B4-4775-A164-E5DE68061265Q37975121-6FACED89-0D77-4590-9A2A-7C2673CDE494Q38079565-79B40183-85FC-4D8D-A51C-C0F5FF7B346AQ38174213-5E51EB7C-1750-4122-A71A-1F1CF9482A65Q38726564-46A3E8CA-0C3F-4E62-A8EF-8A3C3B8717E0Q38790527-39E942DB-CF6C-4823-A141-CBEDF9ABC2A5Q38978490-68918A07-FE30-4432-97B7-CC5784BA5473Q47599527-8FCF2748-3AAC-4936-9B97-B0AEB9C36D78Q48168933-82DD6389-02A8-49F9-B34D-84591366AF43Q51339924-11F03E6F-E08C-4E43-908E-DDA92024BAF2Q53383705-1B2AEB97-E726-429B-A0B1-CD3A4BCFBE1EQ54559714-33096A44-8121-46D6-934D-B24C7280DFF9Q55069411-787876B0-849D-4B71-8FEC-B8F1AB8302D1Q55295121-003866F7-8F22-4DFA-B524-D5F0F2659400Q56864031-AB724505-FD7F-45DD-934F-F47115AA6F17
P2860
Atrial fibrillation and heart failure: natural history and pharmacological treatment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Atrial fibrillation and heart failure: natural history and pharmacological treatment.
@ast
Atrial fibrillation and heart failure: natural history and pharmacological treatment.
@en
type
label
Atrial fibrillation and heart failure: natural history and pharmacological treatment.
@ast
Atrial fibrillation and heart failure: natural history and pharmacological treatment.
@en
prefLabel
Atrial fibrillation and heart failure: natural history and pharmacological treatment.
@ast
Atrial fibrillation and heart failure: natural history and pharmacological treatment.
@en
P1433
P1476
Atrial fibrillation and heart failure: natural history and pharmacological treatment.
@en
P2093
A John Camm
Irina Savelieva
P356
10.1016/J.EUPC.2004.07.003
P478
P577
2004-09-01T00:00:00Z